Condensed Balance Sheets - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Assets, Current [Abstract]
Cash		$ 814,170	$ 0
Prepaid expenses		384,878
Total Current assets		1,199,048
Deferred offering costs			463,629
Long-term prepaid expenses		121,065
Cash and marketable securities held in Trust Account		236,914,324
TOTAL ASSETS		238,234,437	463,629
Current liabilities
Accrued expenses		153,639
Accrued offering costs		75,320	303,895
Promissory note – related party			138,461
Total Current liabilities		228,959	442,356
Warrant liabilities		5,946,060
Convertible promissory note - related party, at fair value		4,165,549
Deferred underwriting fee		11,500,000
TOTAL LIABILITIES		21,840,568	442,356
Commitments and Contingencies
Class A ordinary shares subject to possible redemption 23,000,000 and 0 shares at redemption value at June 30, 2022 and December 31, 2021		236,914,324
SHAREHOLDERS' (DEFICIT) EQUITY
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued and outstanding (excluding 23,000,000 and 0 shares subject to possible redemption) at June 30, 2022 and December 31, 2021
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding at June 30, 2022 and December 31, 2021	[1]	575	575
Additional paid-in capital			24,425
Accumulated deficit		(20,521,030)	(3,727)
TOTAL SHAREHOLDERS' (DEFICIT) EQUITY		(20,520,455)	21,273
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY		$ 238,234,437	$ 463,629

[1] At December 31, 2021, this number included an aggregate of up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. As a result of the underwriters’ full exercise of their over-allotment option on the closing date of the Initial Public Offering, at June 30, 2022 there are no Class B ordinary shares subject to forfeiture (see Note 5).